Home LiteratureArticle Details
PMID: 22258181 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

A multi-ethnic study of a PNPLA3 gene variant and its association with disease severity in non-alcoholic fatty liver disease.

Human genetics ·Vol. 131 ·No. 7 ·2012-07-00 ·Pages 1145-52

Zain SM, Mohamed R, Mahadeva S, Cheah PL, Rampal S, Basu RC, Mohamed Z

Abstract

The adiponutrin (PNPLA3) rs738409 polymorphism has been found to be associated with susceptibility to non-alcoholic fatty liver disease (NAFLD) in various cohorts. We further investigated the association of this polymorphism with non-alcoholic steatohepatitis (NASH) severity and with histological features of NAFLD. A total of 144 biopsy-proven NAFLD patients and 198 controls were genotyped for PNPLA3 gene polymorphism (rs738409 C>G). The biopsy specimens were histologically graded by a qualified pathologist. We observed an association of G allele with susceptibility to NAFLD in the pooled subjects (OR 2.34, 95% CI 1.69-3.24, p < 0.0001), and following stratification, in each of the three ethnic subgroups, namely Chinese, Indian and Malay (OR 1.94, 95% CI 1.12-3.37, p = 0.018; OR 3.51, 95% CI 1.69-7.26, p = 0.001 and OR 2.05, 95% CI 1.25-3.35, p = 0.005, respectively). The G allele is associated with susceptibility to NASH (OR 2.64, 95% CI 1.85-3.75, p < 0.0001), with NASH severity (OR 1.85, 95% CI 1.05-3.26, p = 0.035) and with presence of fibrosis (OR 1.95, 95% CI 1.17-3.26, p = 0.013) but not with simple steatosis nor with other histological parameters. Although the serum triglyceride level is significantly higher in NAFLD patients compared to controls, the G allele is associated with decreased level of triglycerides (p = 0.029) in the NAFLD patients. Overall, the rs738409 G allele is associated with severity of NASH and occurrence of fibrosis in patients with NAFLD.

MeSH Terms
Alleles Body Mass Index Case-Control Studies Fatty Liver/genetics,pathology Female Gene Frequency Genetic Predisposition to Disease Genetic Variation Genotype Humans Lipase/genetics Liver/pathology Liver Cirrhosis/genetics Male Membrane Proteins/genetics Middle Aged Non-alcoholic Fatty Liver Disease Polymorphism, Single Nucleotide Triglycerides/blood
Chemicals
Membrane Proteins Triglycerides Lipase adiponutrin, human
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Zain Shamsul Mohd
The Pharmacogenomics Laboratory, Department of Pharmacology, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia. [email protected]
Mohamed Rosmawati
Mahadeva Sanjiv
Cheah Phaik Leng
Rampal Sanjay
Basu Roma Choudhury
Mohamed Zahurin
References (35)
35 references, click to expand
  1. Design and validation of a histological scoring system for nonalcoholic fatty liver disease.
    Hepatology. 2005 Jun;41(6):1313-21 PMID: 15915461
  2. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study.
    Am J Gastroenterol. 2009 Apr;104(4):861-7 PMID: 19293782
  3. Genetic influences in nonalcoholic fatty liver disease.
    J Clin Gastroenterol. 2006 Mar;40 Suppl 1:S30-3 PMID: 16540764
  4. A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity.
    J Lipid Res. 2009 Oct;50(10):2111-6 PMID: 19738004
  5. Heritability of nonalcoholic fatty liver disease.
    Gastroenterology. 2009 May;136(5):1585-92 PMID: 19208353
  6. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management.
    Hepatology. 2009 Jan;49(1):306-17 PMID: 19065650
  7. A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans.
    Diabetologia. 2009 Jun;52(6):1056-60 PMID: 19224197
  8. From the metabolic syndrome to NAFLD or vice versa?
    Dig Liver Dis. 2010 May;42(5):320-30 PMID: 20207596
  9. Genetic variation, classification and 'race'.
    Nat Genet. 2004 Nov;36(11 Suppl):S28-33 PMID: 15508000
  10. Molecular mechanisms involved in NAFLD progression.
    J Mol Med (Berl). 2009 Jul;87(7):679-95 PMID: 19352614
  11. PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease.
    Hepatology. 2010 Sep;52(3):904-12 PMID: 20648472
  12. Joint effects of body weight and alcohol on elevated serum alanine aminotransferase in the United States population.
    Clin Gastroenterol Hepatol. 2005 Dec;3(12):1260-8 PMID: 16361053
  13. Association of PNPLA3 SNP rs738409 with liver density in African Americans with type 2 diabetes mellitus.
    Diabetes Metab. 2011 Nov;37(5):452-5 PMID: 21665509
  14. Genetic and environmental susceptibility to non-alcoholic fatty liver disease.
    Dig Dis. 2010;28(1):255-60 PMID: 20460920
  15. Nonalcoholic fatty liver disease.
    N Engl J Med. 2002 Apr 18;346(16):1221-31 PMID: 11961152
  16. The effects of diet-induced obesity on hepatocyte insulin signaling pathways and induction of non-alcoholic liver damage.
    Int J Gen Med. 2011 Mar 15;4:211-9 PMID: 21475632
  17. Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings.
    Hepatology. 2011 Mar;53(3):810-20 PMID: 21319198
  18. A common variant in the PNPLA3 gene is a risk factor for non-alcoholic fatty liver disease in obese Taiwanese children.
    J Pediatr. 2011 May;158(5):740-4 PMID: 21168155
  19. Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis.
    Diabetes Metab. 2008 Dec;34(6 Pt 2):634-7 PMID: 19195623
  20. Mechanisms of disease progression in nonalcoholic fatty liver disease.
    Semin Liver Dis. 2008 Nov;28(4):370-9 PMID: 18956293
  21. [Nonalcoholic fatty liver disease in a severely obese adolescent. An arguable liver biopsy].
    Arch Pediatr. 2011 Jan;18(1):62-5 PMID: 21130626
  22. Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease.
    BMC Med Genet. 2010 Dec 22;11:172 PMID: 21176169
  23. Nonalcoholic fatty liver disease.
    CMAJ. 2005 Mar 29;172(7):899-905 PMID: 15795412
  24. Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: pathogenetic role of genetic background and intrauterine environment.
    Ann Med. 2012 Feb;44(1):29-40 PMID: 21355790
  25. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease.
    Nat Genet. 2008 Dec;40(12):1461-5 PMID: 18820647
  26. Nonalcoholic fatty liver disease: a review of current understanding and future impact.
    Clin Gastroenterol Hepatol. 2004 Dec;2(12):1048-58 PMID: 15625647
  27. Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene.
    Diabetes. 2009 Nov;58(11):2616-23 PMID: 19651814
  28. The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease.
    Hepatology. 2010 Sep;52(3):894-903 PMID: 20684021
  29. Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities.
    J Biol Chem. 2004 Nov 19;279(47):48968-75 PMID: 15364929
  30. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease.
    Hepatology. 2010 Apr;51(4):1209-17 PMID: 20373368
  31. Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course.
    Best Pract Res Clin Gastroenterol. 2004 Dec;18(6):1089-104 PMID: 15561640
  32. The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life.
    J Hepatol. 2010 Aug;53(2):335-8 PMID: 20546964
  33. Recent advances in nonalcoholic fatty liver disease.
    Curr Opin Gastroenterol. 2010 May;26(3):202-8 PMID: 20168226
  34. Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent.
    Int J Obes (Lond). 2010 Jan;34(1):190-4 PMID: 19844213
  35. Genetic evidence on the origins of Indian caste populations.
    Genome Res. 2001 Jun;11(6):994-1004 PMID: 11381027
Article Info
Journal
Human genetics
Abbr.
Hum Genet
ISSN
1432-1203
Published
2012-07-00
Epub
2012-00-19
Pages
1145-52
Language
English
Region
Germany
NLM ID
7613873
PMCID
PMC3374090
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]